🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#TumorBoardTuesday ✅After a brief hiatus for GI ASCO we are back....with another GI case👏 📢Join us Tuesday, 02-25-25 at 8PM ET as Daniel Ahn & Bibin Zheng from Mayo Clinic 🗣️Targeting🎯the FGFR in #cholangiocarcinoma RT and bring others into the discussion‼️

Amazing impactful presentation by the stellar and talented postdocs of Riaz lab team at GUASCO2025.

Sharing a proud moment all our research fellows matched at their top choices Arsalan Mayo Clinic Kainat Cleveland clinic Umair wright medical center Salman landmark Prateek Sinai hospital Baltimore Swati banner del web(phoenix)

Very proud of our research fellows -Great Match results -⁦Irbaz Riaz MD,MS,MBI,PhD⁩ ⁦Neeraj Agarwal, MD, FASCO⁩ ⁦Sumanta K. Pal, MD, FASCO⁩ ⁦Petros Grivas⁩ ⁦Shilpa Gupta⁩ ⁦Yousef Zakharia⁩

Getting ready for Tour De scottsdale to support Hope Foundation. Did close to 3000 ft elevation with Tom today. Please support if you have not done so. The Hope Foundation for Cancer Research Neeraj Agarwal, MD, FASCO Petros Grivas Shilpa Gupta Tanios Bekaii-Saab, MD Mayo Clinic Irbaz Riaz MD,MS,MBI,PhD tourdescottsdale.org/Race/Donate/14…

Very excited about Mayo Clinic Arizona Bold forward with close to 2 Billion $ investment lead by Mitch Humphreys Mitchell Humphreys, MD Mayo Clinic Tanios Bekaii-Saab, MD Irbaz Riaz MD,MS,MBI,PhD

20 years ago, metastatic melanoma meant death in a year. Today? 🔸 10-yr Overall Survival: 43% (nivo+ipi) 🔸 10-yr Melanoma-Specific Survival: 52% This isn’t improvement. It’s a revolution. Believe in science. #Melanoma #Immunotherapy #Oncology #Cancer NEJM @asco ESMO - Eur. Oncology

FDA approves Durva in neoadjuvant chemotherapy for bladder cancer - Practice changing for our patients. Petros Grivas Shilpa Gupta

Lines of Therapy for Locally Advanced/Metastatic Urothelial Carcinoma: The New Paradigm | JCO Oncology Practice ascopubs.org/doi/full/10.12… Sharing our recent review appreciate reviewers for feedback. Great work by Fellow - Oluseyi ‘seyi’ Abidoye Prateek Jain Neeraj Agarwal, MD, FASCO Petros Grivas Shilpa Gupta

Hope foundation is ready for Tour de scottsdale tomorrow SWOG Cancer Research Network Seth lerner Neeraj Agarwal, MD, FASCO Petros Grivas Shilpa Gupta already collected over 25k to fund early investigator training course this year . Looking forward to the ride

Hit our goal for this year fundraiser . All the donations will go to support this year early investigator course at SWOG. Thank you all for your support SWOG Cancer Research Network splernerMD Joshua Meeks Neeraj Agarwal, MD, FASCO Petros Grivas Shilpa Gupta Sumanta K. Pal, MD, FASCO Sameer Keole Mayo Clinic Mitchell Humphreys, MD

So happy and proud to share our recent publication on the much talked about topic of Bladder Preservation in NMIBC/MIBC, under the expert mentorship of Dr. Singh. Truly grateful for Dr. Singh’s guidance 🙏🏻😊😇. Parminder singh Mark Tyson Adri Durant link.springer.com/article/10.100…

Day 1 of the SWOG Cancer Research Network spring group meeting in SF! New CRAs spend the day in our Clin Trials Training Course, & our #NCORP research cmtes all meet today. 1 symposium on engaging older patients and another on engaging AYAs. Learn more: swog.org/news-events/sw… #SWOGonc

🚨 New Uromigos episode alert! Dr. Mark Tyson from the Mayo Clinic joins Brian Rini, MD Tom Powles to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC. 🎙️ GU Oncology Now: buff.ly/kRshgKl 🍎 Apple Podcasts: buff.ly/wKcpg2D

Okay. This photo in the SWOG Cancer Research Network meeting lobby totally made my day! It's the 25th anniversary of the The Hope Foundation for Cancer Research-hosted #YITC. Check out all the amazing folks that have been thru the course since Day 1. I spy Neeraj Agarwal, MD, FASCO, Parminder singh, H. Jack West, MD, FASCO, Syed A. Ahmad, Reshma Jagsi,

Early therapeutics and rare tumor committee. Great group to brainstorm new ideas. ⁦SWOG Cancer Research Network⁩ ⁦Young Kwang Chae, MD, MPH, MBA⁩ ⁦Sumanta K. Pal, MD, FASCO⁩

What a proud moment for a parent of rising high school senior presenting her first research study . Thank you Dr Morrison for your mentorship@WPAwesternpsych

Grand rounds at Mayo Clinic -can we cure advanced kidney cancer . What an engaging talk by Yousef Zakharia Irbaz Riaz MD,MS,MBI,PhD Tanios Bekaii-Saab, MD Mayo Clinic Daniel Heng Brian Rini, MD

🚨 NEW in European Urology! A living meta-analysis reveals heterogeneity in PARP inhibitor efficacy for mCRPC. 🔍 BRCA-altered tumors = most benefit ⚠️ No clear advantage in ATM/CHEK2 🧬 Gene-by-gene insights 📖 Read now: buff.ly/9IjKPPg #ProstateCancer #PARP #mCRPC

#insurance denial - How do you respond to insurance denial when they state that approval of Enhertu in bladder cancer was based on small phase II and the insurance would not accept this approval